Search Results - "Peña‐Hernandez, Armando"

Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes by Luna‐Fineman, Sandra, Castellanos, Mauricio, Metzger, Monika L., Baez, L. Fulgencio, Peña Hernandez, Armando, Bonilla, Miguel, Fuentes‐Alabi, Soad, Nieves, Rosa, Blanco, Jessica, Rossi, Emanuela, Devidas, Meenakshi, Chen, Yichen, Arreola, Magda, Alarcon, Pedro A.

“…Background/objectives High‐risk Hodgkin lymphoma (HRHL) in children is curable with combined modality therapy. The Association of Pediatric Hematology‐Oncology…”
Get full text

Outcome of pediatric non‐Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA) by Peña‐Hernandez, Armando, Ortiz, Roberta, Garrido, Claudia, Gomez‐Garcia, Wendy, Fuentes‐Alabi, Soad, Martinez, Roxana, Metzger, Monika L., Chantada, Guillermo L., Ribeiro, Raul C.

“…Background Treating B–non‐Hodgkin lymphoma (B‐NHL) in lower‐income countries is challenging because of imprecise diagnosis, the increased risk of fatal…”
Get full text

Improving childhood cancer care in Latin America and the Caribbean: a PAHO Childhood Cancer Working Group position statement by Denburg, Avram, Cuadrado, Cristóbal, Alexis, Cheryl, Klussmann, Federico Antillón, Zamora, José Carlos Barrantes, Bodkyn, Curt, Bull, Myriam Campbell, Alvarez, Gustavo Dufort y, Gooding, Latoya, Kutluk, Tezer, Luciani, Silvana, Marcillo, Jessyca Karina Manner, Martins, Sandro, Metzger, Monika, Vera, Anyul Milena, Moreno, Florencia, Noguera, Jabibi, Hernandez, Armando Pena, Delgado, Karina Quintero, Richards-Dawson, Michelle-Ann, Scopinaro, Marcelo, Klincovstein, Jaime Shalkow, Sinquee-Brown, Corrine, Suarez, Amaranto, Torode, Julie, Verdecia, Caridad, Vásquez, Roberto Franklin, Gupta, Sumit

“…Medical and health system advances have brought cure to more than 80% of children with cancer in high-income countries (HICs),1 but such advances have eluded…”
Get full text

A Risk-Adapted, Response-Based Therapeutic Regimen Using a Modified Stanford V Approach for the Treatment of Children with High Risk Hodgkin Lymphoma, AHOPCA LH 2004, a therapeutic regimen from the Central America and Dominican Republic Association of Pediatric Oncology by Castellanos, E. Mauricio, Metzger, Monika, Baez, L. Fulgencio, Gamboa, Yessica, Hernandez, Armando Pena, Alabi, Soad, Luna-Fineman, Sandra, Nieves, Rosa, de Alarcon, Pedro

“…Abstract 718 Hodgkin Lymphoma (HL) is highly curable with reported event-free survival (EFS) estimates of greater than 80% even in high-risk patients…”
Get full text